A researcher has hailed "exciting" results from a study into a treatment for the hair loss condition alopecia areata. A relatively common condition, alopecia areata is thought to affect 1 in every 500 ...

The U.S. Food and Drug Administration on Friday approved an alopecia treatment for kids, marking a historic first. The drug, ritlecitinib, is a once-daily pill for kids ages 12 and older with severe ...

Is male baldness preventable? Here is what doctors want you to know about the treatment process for managing male alopecia.

Autologous fat grafting offers hope for patients with alopecia, especially those with scarring, by reducing inflammation and stimulating hair growth. Patients with alopecia are either diagnosed with ...

This article was reviewed by Knox Beasley, MD. Retrograde alopecia is a form of hair loss characterized by the gradual thinning or recession of hair at the nape of the neck or the sides of the scalp.

Apropos of absolutely nothing, scientists announced this week that a common arthritis medication appears to help alopecia patients regrow their hair — a significant potential treatment for a ...

Olumiant and other drugs like it had already been approved to treat autoimmune conditions like rheumatoid arthritis, but used off-label for alopecia.

For Christian Daniels, it started when his co-worker pointed out a dime-sized bald patch on the back of his head. Within days, he was waking up each morning to find clumps of hair on his white ...

Kristen Whitney, DO, FAAD, determines systemic treatment options for severe alopecia areata based on the patient’s medical history, past treatments tried, potential adverse events, in addition to the ...

The Food and Drug Administration (FDA) has approved a full-body treatment for alopecia areata, an autoimmune disorder that can cause hair loss and baldness occurring in patches on the body, for the ...

A new study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug. The study is based on Phase 3 clinical trials using ...